• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贝伐单抗治疗三年后早产儿视网膜病变复发

Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab.

作者信息

Hajrasouliha Amir R, Garcia-Gonzales Jose M, Shapiro Michael J, Yoon Hawke, Blair Michael P

出版信息

Ophthalmic Surg Lasers Imaging Retina. 2017 Mar 1;48(3):255-259. doi: 10.3928/23258160-20170301-10.

DOI:10.3928/23258160-20170301-10
PMID:28297039
Abstract

Although intravitreal injection of anti-vascular endothelial growth factor agents (IVA) can induce rapid regression of retinopathy of prematurity (ROP), late reactivation of the ROP can occur in the form of tractional retinal detachment (TRD) from contracted recurrent extraretinal fibrovascular proliferation. The authors report a case of bilateral TRD for recurrent ROP in a 3-year-old, which is the latest-reported reactivation to date. The authors propose that persistent avascular retina in eyes that have undergone IVA for ROP receive laser ablation to prevent late recurrences. [Ophthalmic Surg Lasers Imaging Retina. 2017;48:255-259.].

摘要

尽管玻璃体内注射抗血管内皮生长因子药物(IVA)可促使早产儿视网膜病变(ROP)迅速消退,但ROP后期可能会因复发性视网膜外纤维血管增殖收缩导致牵拉性视网膜脱离(TRD)而再次激活。作者报告了一例3岁儿童双侧复发性ROP导致TRD的病例,这是迄今为止报告的最晚再次激活病例。作者建议,对于接受过IVA治疗ROP的眼睛,持续存在的无血管视网膜应接受激光消融,以防止后期复发。[《眼科手术、激光与影像学杂志》。2017年;48:255 - 259。]

相似文献

1
Reactivation of Retinopathy of Prematurity Three Years After Treatment With Bevacizumab.贝伐单抗治疗三年后早产儿视网膜病变复发
Ophthalmic Surg Lasers Imaging Retina. 2017 Mar 1;48(3):255-259. doi: 10.3928/23258160-20170301-10.
2
Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab.玻璃体内注射贝伐单抗单药治疗后早产儿视网膜病变的极晚期复发
Ophthalmic Surg Lasers Imaging Retina. 2016 Mar;47(3):280-3. doi: 10.3928/23258160-20160229-12.
3
Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity.双侧玻璃体内注射贝伐单抗后,一名早产儿发生双侧玻璃体出血。
Ophthalmic Surg Lasers Imaging Retina. 2018 Nov 1;49(11):893-896. doi: 10.3928/23258160-20181101-11.
4
Late-onset tractional fibrovascular proliferation post-intravitreal bevacizumab following treatment of retinopathy of prematurity.早产儿视网膜病变治疗后玻璃体内注射贝伐单抗引起的迟发性牵拉性纤维血管增生
Can J Ophthalmol. 2018 Jun;53(3):e99-e103. doi: 10.1016/j.jcjo.2017.09.028. Epub 2017 Dec 16.
5
Chronic Vascular Arrest as a Predictor of Bevacizumab Treatment Failure in Retinopathy of Prematurity.慢性血管阻塞作为早产儿视网膜病变中贝伐单抗治疗失败的预测因子。
Ophthalmology. 2016 Oct;123(10):2166-75. doi: 10.1016/j.ophtha.2016.06.055. Epub 2016 Aug 6.
6
A Surgical Technique for the Management of Tractional Retinal Detachment in Aggressive Posterior Retinopathy of Prematurity Treated With Intravitreal Bevacizumab.一种用于治疗接受玻璃体内贝伐单抗治疗的侵袭性早产儿视网膜病变所致牵引性视网膜脱离的手术技术。
Retina. 2019 Oct;39 Suppl 1:S156-S159. doi: 10.1097/IAE.0000000000002304.
7
A Dosing Study of Bevacizumab for Retinopathy of Prematurity: Late Recurrences and Additional Treatments.早产儿视网膜病变的bevacizumab 剂量研究:晚期复发和额外治疗。
Ophthalmology. 2018 Dec;125(12):1961-1966. doi: 10.1016/j.ophtha.2018.05.001. Epub 2018 Jun 7.
8
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings.1 型早产儿视网膜病变玻璃体腔内注射贝伐单抗与激光治疗的 4 年随访:荧光血管造影结果。
Ophthalmology. 2018 Feb;125(2):218-226. doi: 10.1016/j.ophtha.2017.08.005. Epub 2017 Sep 1.
9
Reactivation of retinopathy of prematurity after bevacizumab injection.注射贝伐单抗后早产儿视网膜病变复发。
Arch Ophthalmol. 2012 Aug;130(8):1000-6. doi: 10.1001/archophthalmol.2012.592.
10
Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression.1型和2型早产儿视网膜病变接受玻璃体内注射贝伐单抗单药治疗及自然消退后的荧光素血管造影结果比较
Int Ophthalmol. 2019 Oct;39(10):2267-2274. doi: 10.1007/s10792-018-01064-7. Epub 2019 Jan 2.

引用本文的文献

1
Repeat Intravitreal Bevacizumab in a Very Low Birth Weight Infant with Recurrent ROP: 3-Year Follow-Up and Literature Review.极低出生体重儿复发性视网膜病变的玻璃体内重复注射贝伐单抗:3年随访及文献综述
Case Rep Ophthalmol. 2025 Jun 13;16(1):521-527. doi: 10.1159/000546935. eCollection 2025 Jan-Dec.
2
Clinical Approach and Anatomical Results in the Treatment of Retinopathy of Prematurity.早产儿视网膜病变治疗的临床方法及解剖学结果
Eurasian J Med. 2024 Feb;56(1):52-55. doi: 10.5152/eurasianjmed.2024.23140.
3
Comparing reactivation and retreatment for three doses of bevacizumab in type 1 retinopathy of prematurity.
比较三种剂量贝伐单抗治疗 1 型早产儿视网膜病变的再激活和再治疗。
J AAPOS. 2024 Apr;28(2):103866. doi: 10.1016/j.jaapos.2024.103866. Epub 2024 Mar 6.
4
Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography.基于荧光素眼底血管造影评估玻璃体内雷珠单抗单药或无治疗治疗后消退的早产儿视网膜病变的视网膜血管化。
Sci Rep. 2023 Nov 15;13(1):19946. doi: 10.1038/s41598-023-47212-7.
5
Visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity.抗血管内皮生长因子治疗及激光治疗早产儿视网膜病变后的视野
Graefes Arch Clin Exp Ophthalmol. 2023 Nov;261(11):3207-3213. doi: 10.1007/s00417-023-06227-6. Epub 2023 Sep 6.
6
Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries.抗血管内皮生长因子(Anti-VEGF)在早产儿视网膜病变治疗中的作用:基于中等收入国家背景的叙述性综述
Pediatric Health Med Ther. 2023 Feb 15;14:59-69. doi: 10.2147/PHMT.S391591. eCollection 2023.
7
Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen.21世纪的早产儿视网膜病变及补充氧气的复杂影响。
J Clin Med. 2023 Feb 3;12(3):1228. doi: 10.3390/jcm12031228.
8
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.低剂量和超低剂量贝伐单抗治疗早产儿视网膜病变:再激活、额外治疗和 12 个月的结果。
Ophthalmology. 2022 Oct;129(10):1120-1128. doi: 10.1016/j.ophtha.2022.05.019. Epub 2022 Jun 1.
9
Intravitreal bevacizumab to treat retinopathy of prematurity in 865 eyes: a study to determine predictors of primary treatment failure and recurrence.玻璃体腔内注射贝伐单抗治疗 865 只眼早产儿视网膜病变:一项确定主要治疗失败和复发预测因素的研究。
Int Ophthalmol. 2022 Jul;42(7):2017-2028. doi: 10.1007/s10792-021-02198-x. Epub 2022 Jan 20.
10
Long-term retinal vasculature abnormalities following intravitreal bevacizumab for retinopathy of prematurity.早产儿视网膜病变玻璃体内注射贝伐单抗后长期视网膜血管异常。
Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1915-1921. doi: 10.1007/s00417-021-05499-0. Epub 2021 Dec 1.